A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

NCT02757950 · clinicaltrials.gov ↗

COMPLETED

Status

2462

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria

Interventions

BIOLOGICAL: Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)]

Sponsor

GlaxoSmithKline